ESTIMATING THE IMPACT OF DELAYED TREATMENT FOR MAJOR DEPRESSIVE DISORDER USING A CONTINUOUSTIME PATIENT-LEVEL SIMULATION MODEL

被引：0
|
作者：
Chapman, R. [1 ]
Cheng, M. [1 ]
Xie, R. [2 ]
机构：
[1] Innovat & Value Initiat, Alexandria, VA USA
[2] RA Capital Management, Newton, MA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE501
引用
收藏
页码：S149 / S149
页数：1
相关论文
共 50 条
  • [1] A systematic meta-review of patient-level predictors of psychological therapy outcome in major depressive disorder
    Tanguay-Sela, Myriam
    Rollins, Colleen
    Perez, Tamara
    Qiang, Vivian
    Golden, Grace
    Tunteng, Jingla-Fri
    Perlman, Kelly
    Simard, Jade
    Benrimoh, David
    Margolese, Howard C.
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 317 : 307 - 318
  • [2] Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis
    Gueorguieva, Ralitza
    Chekroud, Adam M.
    Krystal, John H.
    LANCET PSYCHIATRY, 2017, 4 (03): : 230 - 237
  • [3] CALIBRATION OF A PATIENT-LEVEL SIMULATION MODEL FOR DIABETES IN THE ABSENCE OF PATIENT-LEVEL DATA: A PROPOSED METHOD AND HEALTH ECONOMIC IMPLICATIONS
    Tran-Duy, A.
    Palmer, A.
    Dakin, H.
    Leal, J.
    Clarke, P.
    VALUE IN HEALTH, 2024, 27 (06) : S7 - S7
  • [4] Clustering patients by depression symptoms may predict treatment outcomes for major depressive disorder: Patient-level meta-analysis of venlafaxine extended release trials
    Kato, M.
    Asami, Y.
    Boucher, M.
    Pappadopulos, E.
    Prieto Lopez, R.
    Wang, X.
    Wajsbrot, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S417 - S418
  • [5] A PATIENT-LEVEL SIMULATION MODEL FOR ECONOMIC EVALUATION OF CINACALCET IN THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM (SHPT) IN ITALY
    Eandi, M.
    Pradelli, L.
    Iannazzo, S.
    Chiroli, S.
    Pontoriero, G.
    VALUE IN HEALTH, 2009, 12 (07) : A406 - A406
  • [6] Optimizing patient expectancy in the pharmacologic treatment of major depressive disorder
    Zilcha-Mano, Sigal
    Brown, Patrick J.
    Roose, Steven P.
    Cappetta, Kiley
    Rutherford, Bret R.
    PSYCHOLOGICAL MEDICINE, 2019, 49 (14) : 2414 - 2420
  • [7] A Canadian Simulation Model for Major Depressive Disorder: Study Protocol
    Ghanbarian, Shahzad
    Wong, Gavin W. K.
    Bunka, Mary
    Edwards, Louisa
    Cressman, Sonya
    Conte, Tania
    Peterson, Sandra
    Vijh, Rohit
    Price, Morgan
    Schuetz, Christian
    Erickson, David
    Riches, Linda
    Landry, Ginny
    McGrail, Kim
    Austin, Jehannine
    Bryan, Stirling
    PHARMACOECONOMICS-OPEN, 2024, 8 (03) : 493 - 505
  • [8] A Canadian Simulation Model for Major Depressive Disorder: Study Protocol
    Shahzad Ghanbarian
    Gavin W. K. Wong
    Mary Bunka
    Louisa Edwards
    Sonya Cressman
    Tania Conte
    Sandra Peterson
    Rohit Vijh
    Morgan Price
    Christian Schuetz
    David Erickson
    Linda Riches
    Ginny Landry
    Kim McGrail
    Jehannine Austin
    Stirling Bryan
    PharmacoEconomics - Open, 2024, 8 : 493 - 505
  • [9] EVALUATING DIFFERENT MODES OF RADIOTHERAPY BASED ON A PATIENT-LEVEL SIMULATION MODEL
    Quik, E. H.
    Feenstra, T. L.
    Postmus, D.
    Krabbe, P. F. M.
    Langendijk, H.
    VALUE IN HEALTH, 2013, 16 (07) : A580 - A580
  • [10] Using patient-level simulation to model patient-centric outcomes in the advent of gene therapy in severe haemophilia A
    O'Hara, J.
    Jain, M.
    Stevenson, M.
    Burke, T.
    Camp, C.
    HAEMOPHILIA, 2019, 25 : 66 - 67
12345